The only company conducting FDA-approved clinical trials using human embryonic stem cells (hESC) is now calling a halt to the trials. Not only have the trials stopped, but the company, Geron, which has been considered a leader in the field, indicated that it will be turning its resources to projects other than stem cell research. Read more at LifeNews.com.